Published in Biochem Biophys Res Commun on July 29, 1988
Apolipoprotein (apo) E inhibits the capacity of monosodium urate crystals to stimulate neutrophils. Characterization of intraarticular apo E and demonstration of apo E binding to urate crystals in vivo. J Clin Invest (1991) 1.12
Association of apolipoprotein E polymorphisms and dietary factors in colorectal cancer. Br J Cancer (2009) 0.89
Isolation from fetal bovine serum of an apolipoprotein-H-like protein which inhibits thymidine incorporation in fetal calf erythroid cells. Biochem J (1990) 0.77
Apo B100 similarities to viral proteins suggest basis for LDL-DNA binding and transfection capacity. J Lipid Res (2010) 0.76
Mechanism of action and in vitro activity of 1',3'-dioxolanylpurine nucleoside analogues against sensitive and drug-resistant human immunodeficiency virus type 1 variants. Antimicrob Agents Chemother (1999) 1.26
Ornithine decarboxylase induction and polyamine biosynthesis are required for the growth of interleukin-2- and interleukin-3-dependent cell lines. Cell Immunol (1986) 1.16
Activation of adenosine A3 receptors on macrophages inhibits tumor necrosis factor-alpha. Eur J Pharmacol (1996) 1.06
Polyamine oxidation down-regulates IL-2 production by human peripheral blood mononuclear cells. J Immunol (1989) 1.05
Modulation of osteogenic cell ultrastructure by RS-23581, an analog of human parathyroid hormone (PTH)-related peptide-(1-34), and bovine PTH-(1-34). Endocrinology (1995) 1.03
Signal epitopes in the three-dimensional structure of neuropeptide Y. Interaction with Y1, Y2, and pancreatic polypeptide receptors. Ann N Y Acad Sci (1990) 1.01
Inhibition of superantigen-induced proinflammatory cytokine production and inflammatory arthritis in MRL-lpr/lpr mice by a transcriptional inhibitor of TNF-alpha. J Immunol (1996) 1.01
Increased polyamines may downregulate interleukin 2 production in rheumatoid arthritis. J Clin Invest (1989) 0.99
Carbocyclic nucleosides as inhibitors of human tumor necrosis factor-alpha production: effects of the stereoisomers of (3-hydroxycyclopentyl)adenines. J Med Chem (1996) 0.98
High affinity type I interleukin 1 receptor antagonists discovered by screening recombinant peptide libraries. Proc Natl Acad Sci U S A (1996) 0.97
Antiretroviral activity of castanospermine and deoxynojirimycin, specific inhibitors of glycoprotein processing. Biochem Biophys Res Commun (1987) 0.95
A heparin which binds to the envelope glycoprotein gp120 inhibits human immunodeficiency virus replication. Trans Assoc Am Physicians (1989) 0.93
Drug resistance and drug combination features of the human immunodeficiency virus inhibitor, BCH-10652 [(+/-)-2'-deoxy-3'-oxa-4'-thiocytidine, dOTC]. Antivir Chem Chemother (2000) 0.92
Minimal peptide length for interaction of amphipathic alpha-helical peptides with phosphatidylcholine liposomes. Biochemistry (1991) 0.92
Interaction of hirudin with thrombin: identification of a minimal binding domain of hirudin that inhibits clotting activity. Biochemistry (1988) 0.90
AF12198, a novel low molecular weight antagonist, selectively binds the human type I interleukin (IL)-1 receptor and blocks in vivo responses to IL-1. J Biol Chem (1996) 0.90
Intracellular polyamine biosynthesis is required for interleukin 2 responsiveness during lymphocyte mitogenesis. Cell Immunol (1987) 0.90
Effect of the hirudin carboxy-terminal peptide 54-65 on the interaction of thrombin with platelets. Thromb Haemost (1991) 0.90
6-0-butanoylcastanospermine (MDL 28,574) inhibits glycoprotein processing and the growth of HIVs. AIDS (1991) 0.89
The effect of alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, on mitogen-induced interleukin 2 production. Immunopharmacology (1987) 0.89
Antithrombin properties of C-terminus of hirudin using synthetic unsulfated N alpha-acetyl-hirudin45-65. FEBS Lett (1987) 0.87
The effects of selective amino acid substitution upon neuropeptide Y antisecretory potency in rat jejunum mucosa. Peptides (1991) 0.87
Biologic properties of interleukin 3. II. Serologic comparison of 20-alpha-SDH-inducing activity, colony-stimulating activity, and WEHI-3 growth factor activity by using an antiserum against IL 3. J Immunol (1984) 0.85
Refined crystal structure of the interleukin-1 receptor antagonist. Presence of a disulfide link and a cis-proline. Eur J Biochem (1995) 0.85
Stilbene disulfonic acids. CD4 antagonists that block human immunodeficiency virus type-1 growth at multiple stages of the virus life cycle. J Biol Chem (1991) 0.84
Structures of thrombin complexes with a designed and a natural exosite peptide inhibitor. J Biol Chem (1993) 0.84
Increased ornithine decarboxylase activity and polyamine biosynthesis are required for optimal cytolytic T lymphocyte induction. Cell Immunol (1987) 0.84
Antiretroviral activity of mechanism-based irreversible inhibitors of S-adenosylhomocysteine hydrolase. Life Sci (1992) 0.83
Immunomodulation by an inhibitor of S-adenosyl-L-homocysteine hydrolase: inhibition of in vitro and in vivo allogeneic responses. Cell Immunol (1993) 0.83
Effect of polyamine depletion in vivo by DL-alpha-difluoromethylornithine on functionally distinct populations of tumoricidal effector cells in normal and tumor-bearing mice. Cancer Res (1986) 0.83
Selective inhibition of T cell activation by an inhibitor of S-adenosyl-L-homocysteine hydrolase. J Immunol (1993) 0.83
A high throughput colorimetric cell proliferation assay for the identification of human cytomegalovirus inhibitors. Antiviral Res (1999) 0.82
RS-66271, a C-terminally substituted analog of human parathyroid hormone-related protein (1-34), increases trabecular and cortical bone in ovariectomized, osteopenic rats. J Bone Miner Res (1996) 0.82
Importance of the 10-13 region of glucagon for its receptor interactions and activation of adenylate cyclase. Biochemistry (1986) 0.81
The dogfish peptides scyliorhinin I and scyliorhinin II bind with differential selectivity to mammalian tachykinin receptors. Eur J Pharmacol (1987) 0.81
Anti-HIV activity of castanospermine analogues. Lancet (1989) 0.81
A tachykinin peptide receptor joins an elite club. Trends Pharmacol Sci (1988) 0.80
Mixtures of synthetic peptides and dipalmitoylphosphatidylcholine as lung surfactants. Am J Physiol (1992) 0.80
Effect of murine alpha-, beta-, and gamma-interferons in combination with alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, on the tumor growth and metastasis of B16 melanoma and Lewis lung carcinoma in mice. J Biol Response Mod (1989) 0.80
Potent antitumor activity of a novel nucleoside analogue, BCH-4556 (beta-L-dioxolane-cytidine), in human renal cell carcinoma xenograft tumor models. Cancer Res (1997) 0.80
Regulation of IL-2 production by mononuclear cells from rheumatoid arthritis synovial fluids. Clin Exp Immunol (1992) 0.80
Human aortic endothelial cells express the type I but not the type II receptor for interleukin-1 (IL-1). J Cell Physiol (1992) 0.80
Selection and characterization of human immunodeficiency virus type 1 variants resistant to the (+) and (-) enantiomers of 2'-deoxy-3'-oxa-4'-thio-5-fluorocytidine. Antimicrob Agents Chemother (2000) 0.79
Anticoagulant peptides: nature of the interaction of the C-terminal region of hirudin with a noncatalytic binding site on thrombin. J Med Chem (1987) 0.79
Activation of neuropeptide Y1 and neuropeptide Y2 receptors by substituted and truncated neuropeptide Y analogs: identification of signal epitopes. Eur J Pharmacol (1993) 0.79
Inhibition of glycoprotein processing and HIV replication by castanospermine analogues. Ann N Y Acad Sci (1990) 0.78
Disruption of Plasmodium falciparum-infected erythrocyte cytoadherence to human melanoma cells with inhibitors of glycoprotein processing. Biochem Pharmacol (1991) 0.78
A new approach to conformationally restricted peptide analogs: rigid beta-bends. 1. Enkephalin as an example. Biochem Biophys Res Commun (1982) 0.78
Examination of the peptide sequence requirements for lipid-binding. Alternative pathways for promoting the interaction of amphipathic alpha-helical peptides with phosphatidylcholine. Biochim Biophys Acta (1991) 0.78
The fibrinogen anion-binding exosite of thrombin is necessary for induction of rises in intracellular calcium and prostacyclin production in endothelial cells. J Cell Physiol (1992) 0.78
Neuropeptide Y and truncated neuropeptide Y analogs evoke histamine release from rat peritoneal mast cells. A direct effect on G proteins? Eur J Pharmacol (1994) 0.78
Antitumor activity of norspermidine, a structural homologue of the natural polyamine spermidine. Anticancer Res (1988) 0.78
4',5'-unsaturated 5'-halogenated nucleosides. Mechanism-based and competitive inhibitors of S-adenosyl-L-homocysteine hydrolase. J Med Chem (1991) 0.78
Examination of the role of the amphipathic alpha-helix in the interaction of neuropeptide Y and active cyclic analogues with cell membrane receptors and dimyristoylphosphatidylcholine. Biochemistry (1990) 0.78
Identification of a specific receptor for interleukin-1 in vascular smooth muscle cells: regulation by interleukin-1 and interleukin-6. Eur J Pharmacol (1993) 0.77
Studies on the anticoagulant, antimetastatic and heparin-binding properties of ghilanten-related inhibitors. Blood Coagul Fibrinolysis (1991) 0.77
Heparin binding properties of the carboxyl terminal domain of [A103,106,108] antistasin 93-119. Adv Exp Med Biol (1992) 0.77
Centrally truncated neuropeptide Y analog acts as an agonist for Y1 receptors on SK-N-MC cells. Neurosci Lett (1990) 0.77
Antitumor activity of a novel synthetic polyamine analogue, N,N'-bis-[3-(ethylamino)-propyl]-1-7-heptane diamine: potentiation by polyamine oxidase inhibitors. Anticancer Res (1990) 0.77
Structural properties of the heparin-binding domains of human apolipoprotein E. Adv Exp Med Biol (1988) 0.77
Accumulation of pentamannose oligosaccharides in human mononuclear leukocytes by action of swainsonine, an inhibitor of glycoprotein processing. Carbohydr Res (1993) 0.77
Selection and characterization of HIV-1 variants resistant to the (+) and (-) enantiomers of 2'-deoxy-3'-oxa-4'-thiocytidine (dOTC). Antivir Ther (1999) 0.77
Effect of micelle diameter on tryptophan dynamics in an amphipathic helical peptide in phosphatidylcholine. Biochemistry (1989) 0.76
Methylacetylenic putrescine (MAP), an inhibitor of polyamine biosynthesis, prevents the development of collagen-induced arthritis. Cell Immunol (1990) 0.76
Characterization of a monoclonal antibody specific to the amino terminus of the alpha-chain of human fibrin. Thromb Haemost (1990) 0.76
An amphipathic alpha-helical decapeptide in phosphatidylcholine is an effective synthetic lung surfactant. Am Rev Respir Dis (1993) 0.75
N-terminal requirements of small peptide anticoagulants based on hirudin54-65. J Med Chem (1988) 0.75
Demonstration that [A103,106,108] antistasin 93-119 inhibits the specific binding of antistasin to sulfatide [Gal(3-SO4)beta 1-1Cer]. Biochem Biophys Res Commun (1991) 0.75
Evidence for a lysine-specific fragmentation in fast-atom bombardment mass spectra of peptides. Rapid Commun Mass Spectrom (1992) 0.75
The immune response to a chemically induced fibrosarcoma: a comparison of cytolytic T lymphocyte stimulation by transformed and non-transformed fibroblasts. Cancer Immunol Immunother (1982) 0.75
Antithrombotic activity of a novel C-terminal hirudin analog in experimental animals. Thromb Haemost (1991) 0.75
Mechanism of antitumor activity of norspermidine, a structural homologue of spermidine. Adv Exp Med Biol (1988) 0.75
Lipid and membrane interactions of neuropeptide Y. Biochim Biophys Acta (1990) 0.75
The effect of alpha-difluoromethylornithine on natural killer cell and tumoricidal macrophage induction by interferon in vivo. Int J Immunopharmacol (1986) 0.75
In vitro inhibition of allogeneic CTL generation and interferon gamma production by the cells of a chemically induced fibrosarcoma. J Interferon Res (1983) 0.75
Specific inhibition of binding of antistasin and [A103,106,108] antistasin 93-119 to sulfatide (Gal(3-SO4)beta 1-1Cer) by glycosaminoglycans. FEBS Lett (1992) 0.75
Binding of fluorescent and spin-labeled C-terminal hirudin analogs to thrombin. J Med Chem (1994) 0.75
Structure-function studies on positions 17, 18, and 21 replacement analogues of glucagon: the importance of charged residues and salt bridges in glucagon biological activity. J Med Chem (1998) 0.75
Specific interaction of 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid with human cellular CD4. Cell Immunol (1994) 0.75
Preparation of antibodies to a synthetic C terminus of hirudin and identification of an antigenic site. J Immunol Methods (1989) 0.75
Antithrombotic activity of a novel C-terminal hirudin analog in experimental animals. Thromb Haemost (1991) 0.75
The effect of combination treatment with alpha-difluoromethylornithine and Corynebacterium parvum on B16 melanoma growth and tumoricidal effector cell generation in vivo. Cancer Immunol Immunother (1985) 0.75
Combinatorial synthesis of small-molecule libraries using 3-amino-5-hydroxybenzoic acid. Mol Divers (1996) 0.75
Human hepatoma (HepG2) cells secrete a single 65 K dalton triglyceride lipase immunologically identical to postheparin plasma hepatic lipase. Life Sci (1989) 0.75
Rapid purification and revised amino-terminal sequence of hirudin: a specific thrombin inhibitor of the bloodsucking leech. Anal Biochem (1987) 0.75
Positional effects of sulfation in hirudin and hirudin PA related anticoagulant peptides. J Med Chem (1991) 0.75